Swiss Cancer Center Léman (SCCL) Switzerland

Research

Date range: 1 April 2021 - 31 March 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Swiss Cancer Center Léman (SCCL) published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Swiss Cancer Center Léman (SCCL)
Count Share
4 1.45

Outputs by subject (Share)

Outputs by subject
Subject Count Share
4 1.45
1 0.32

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.00 0.62 0.95

Compare Swiss Cancer Center Léman (SCCL) with other institutions

Collaboration

Date range: 1 April 2021 - 31 March 2022

International vs. domestic collaboration by Share

  • 59.44% Domestic
  • 40.56% International

Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators with Swiss Cancer Center Léman (SCCL) by Share (4 total)

  1. Swiss Cancer Center Léman (SCCL) and University of Lausanne (UNIL) (2.52)
    Swiss Cancer Center Léman (SCCL)1.45
    University of Lausanne (UNIL)1.07
  2. Swiss Cancer Center Léman (SCCL) and Swiss Federal Institute of Technology Lausanne (EPFL) (2.42)
    Swiss Cancer Center Léman (SCCL)1.45
    Swiss Federal Institute of Technology Lausanne (EPFL)0.97
  3. Swiss Cancer Center Léman (SCCL) and University of Geneva (UNIGE) (2.03)
    Swiss Cancer Center Léman (SCCL)1.45
    University of Geneva (UNIGE)0.58
  4. Swiss Cancer Center Léman (SCCL) and Swiss Institute of Bioinformatics (SIB) (1.35)
    Swiss Cancer Center Léman (SCCL)1.00
    Swiss Institute of Bioinformatics (SIB)0.35

Top 10 international collaborators with Swiss Cancer Center Léman (SCCL) by Share (11 total)

  1. Swiss Cancer Center Léman (SCCL) and Mays Cancer Center (0.95)
    Swiss Cancer Center Léman (SCCL)0.45
    Mays Cancer Center0.50
  2. Swiss Cancer Center Léman (SCCL) and The University of Texas Health Science Center at San Antonio (UT Health San Antonio) (0.75)
    Swiss Cancer Center Léman (SCCL)0.45
    The University of Texas Health Science Center at San Antonio (UT Health San Antonio)0.30
  3. Swiss Cancer Center Léman (SCCL) and The University of Texas MD Anderson Cancer Center (0.70)
    Swiss Cancer Center Léman (SCCL)0.45
    The University of Texas MD Anderson Cancer Center0.25
  4. Swiss Cancer Center Léman (SCCL) and Polytechnic University of Milan (0.46)
    Swiss Cancer Center Léman (SCCL)0.32
    Polytechnic University of Milan0.14
  5. Swiss Cancer Center Léman (SCCL) and Centre d’Immunologie de Marseille-Luminy (CIML) (0.44)
    Swiss Cancer Center Léman (SCCL)0.33
    Centre d’Immunologie de Marseille-Luminy (CIML)0.11
  6. Swiss Cancer Center Léman (SCCL) and Duke University (0.42)
    Swiss Cancer Center Léman (SCCL)0.34
    Duke University0.08
  7. Swiss Cancer Center Léman (SCCL) and The University of Iowa (UI) (0.42)
    Swiss Cancer Center Léman (SCCL)0.34
    The University of Iowa (UI)0.08
  8. Swiss Cancer Center Léman (SCCL) and Vanderbilt University (VU) (0.42)
    Swiss Cancer Center Léman (SCCL)0.34
    Vanderbilt University (VU)0.08
  9. Swiss Cancer Center Léman (SCCL) and Aix-Marseille University (AMU) (0.37)
    Swiss Cancer Center Léman (SCCL)0.33
    Aix-Marseille University (AMU)0.04
  10. Swiss Cancer Center Léman (SCCL) and French National Centre for Scientific Research (CNRS) (0.37)
    Swiss Cancer Center Léman (SCCL)0.33
    French National Centre for Scientific Research (CNRS)0.04

Relationships

Partner Institutions

Swiss Cancer Center Léman (SCCL) is a research collaboration whose article contributions are accrued to its participating partner institutions below.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.